Bonus Apr 05, 2010 Apr 06, 2010 Feb 25, 2010 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Aug 30, 2006 Aug 31, 2006 Apr 28, 2006 Bonus Ratio: 1 share(s) for every 1 shares held Zydus ...

New Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has granted approval to Zydus Healthcare for conducting the Phase III clinical ...

Drugmakers Glenmark Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd. and Zydus are recalling products in the US for manufacturing issues, the Food and Drug Administration said in its latest ...

Glenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and impurities. The USFDA has issued Class II and III recalls for medications like Propafenone, ...

Mouthwash can do so much more than cure bad breath. Thanks to its antibacterial capabilities, there are many properties in this versatile household product that have surprising health benefits ...

Zydus Lifesciences Limited (BSE: 532321, NSE: ZYDUSLIFE) has announced the incorporation of a wholly owned subsidiary, Zydus MedTech (France) SAS, in France. This move is a significant step in the ...

Congress leader P Chidambaram is under observation at Ahmedabad's Zydus Hospital, after he fainted while at the Sabarmati Ashram on Tuesday. His son and Congress MP Karti Chidambaram had earlier ...

Pharma stocks such as Sun Pharma, Aurobindo Pharma, Dr Reddy's Lab, Cipla, Gland Pharma, Zydus Lifesciences and Lupin would be in action on Friday after the US President Donald Trump halted ...

New Delhi: Zydus Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) to conduct the Phase III clinical trial of ...

Biocon's shares fell more than 4 per cent, and Sun Pharma, Lupin, Laurus Labs, Dr Reddy's Laboratories, and Zydus Lifesciences also lost between 2-3 per cent. The steep correction indicates increased ...

Indian pharmaceutical stocks experienced a downturn following Donald Trump's renewed threat to impose tariffs on pharmaceutical imports. The Nifty Pharma index fell by 1.7%, with major companies ...

Among the biggest losers, Gland Pharma Ltd. declined the most, trading 5.48% lower, followed by Zydus Lifesciences Ltd, which fell as much as 3.24%. The third biggest loser was Aurobindo Pharma Ltd, ...